Article

Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men

2011-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 60e59117-4868-5c64-9ee1-21e4ae0cd0b2
DOI: 10.1016/j.yend.2011.04.012

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and MenDOI 10.1016/j.yend.2011.04.012Read

Relation of age, gender, and bone mass to circulating sclerostin levels in women and menSemantic proximity Read

Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humansSemantic proximity Read

The sclerostin story: From human genetics to the development of novel anabolic treatment for osteoporosisSemantic proximity Read

From skeletal to cardiovascular disease in 12 steps—the evolution of sclerostin as a major player in CKD-MBDSemantic proximity Read

Sclerostin deficiency in humansSemantic proximity Read

Endocrine functions of sclerostinSemantic proximity Read

SclerostinSemantic proximity Read

The Role of Sclerostin in Bone DiseasesSemantic proximity Read

Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.Semantic proximity Read

The cause-effect relationship between sclerostin levels, cardiovascular biomarkers, risk factors, and cardiovascular diseaseSemantic proximity Read

Association of Circulating Sclerostin Levels with Fat Mass and Metabolic Disease—Related Markers in Japanese Postmenopausal WomenSemantic proximity Read

Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetesSemantic proximity Read